PRESS RELEASE published on 10/04/2024 at 07:00, 2 years ago Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria Relief Therapeutics reports positive results from RLF-OD032 proof-of-concept clinical study for Phenylketonuria, showing bioequivalence with KUVAN(R) in managing PKU. RLF-OD032 aims to offer a patient-friendly, portable solution for PKU treatment Clinical Study Relief Therapeutics RLF-OD032 Bioéquivalence Phenylketonuria
BRIEF published on 09/23/2024 at 07:05, 2 years 1 month ago Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement FDA Approval Relief Therapeutics Milestone Payment Niemann-Pick Disease SWK Funding
BRIEF published on 09/23/2024 at 07:05, 2 years 1 month ago Relief Therapeutics annonce un jalon de 2 millions de dollars dans le cadre d'un accord de vente de redevances Approbation De La FDA THÉRAPEUTIQUE DE SECOURS Paiement D'étape Maladie De Niemann-Pick Financement SWK
PRESS RELEASE published on 09/23/2024 at 07:00, 2 years 1 month ago Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement Relief Therapeutics announced $2 million milestone payment under royalty sales agreement after FDA approval of arimoclomol for Niemann-Pick Disease Type C treatment FDA Approval Relief Therapeutics Milestone Payment Arimoclomol Royalty Sales Agreement
Published on 10/28/2026 at 02:55, 2 hours 9 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 2 hours 14 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 5 hours 24 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 5 hours 39 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/27/2026 at 21:30, 7 hours 34 minutes ago Apex Announces Closing of Over-Allotment Option
Published on 10/28/2026 at 02:25, 2 hours 39 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 AGM Chair and Group CEO address
Published on 10/28/2026 at 02:19, 2 hours 45 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: September 2026 quarter update
Published on 10/27/2026 at 22:40, 6 hours 24 minutes ago EQS-Adhoc: NEXTDC Limited: Financial Covenants - Compliance and Headroom
Published on 10/27/2026 at 22:30, 6 hours 34 minutes ago Tensor and Münchner Taxi Zentrum Sign LOI to Put Taxi Operators at the Center of Autonomous Mobility in Germany
Published on 10/27/2026 at 20:35, 8 hours 29 minutes ago Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 18:00, 11 hours 4 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 11 hours 4 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
